Factors Influencing Implementation of Blood Transfusion Recommendations in Pediatric Critical Care Units

Katherine M Steffen1, Philip C Spinella2, Laura M Holdsworth3

  • 1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Stanford University, Palo Alto, CA, United States.

Frontiers in Pediatrics
|January 3, 2022
PubMed

Insights

Implementing Transfusion and Anemia eXpertise Initiative (TAXI) recommendations in Pediatric Intensive Care Units (PICUs) faces challenges. Addressing provider buy-in and unit context is key for successful adoption of these guidelines.

Area of Science:

  • Pediatric critical care medicine
  • Health services research
  • Implementation science

Background:

  • Red blood cell transfusions in Pediatric Intensive Care Units (PICUs) carry risks that may exceed benefits for some patients.
  • The Transfusion and Anemia eXpertise Initiative (TAXI) provides recommendations to reduce unnecessary transfusions, but their utilization has been inconsistent.

Purpose of the Study:

  • To identify barriers and facilitators influencing the adoption and use of TAXI recommendations in PICUs.
  • To inform strategies for effective implementation of evidence-based transfusion guidelines.

Main Methods:

  • Semi-structured interviews were conducted with 50 healthcare providers across 8 U.S. ICUs.
  • The integrated Promoting Action on Research Implementation in Health Services (iPARIHS) framework guided data collection and analysis.
  • Adapted Framework analysis categorized data based on iPARIHS constructs to identify implementation patterns.

Main Results:

  • Providers anticipate TAXI recommendations will decrease transfusion rates and practice variability.
  • Challenges to adoption include provider attitudes towards transfusion and the complex PICU environment.
  • Facilitators for implementation include developing buy-in, integrating recommendations into workflow, and appointing champions.

Conclusions:

  • Successful implementation of TAXI recommendations requires targeted strategies for buy-in and education.
  • Acknowledging and adapting to the specific challenges of the PICU environment is crucial for optimizing adoption.
  • A tailored implementation approach considering contextual factors is necessary for effective guideline use.

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.4K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
868
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
15
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
12
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
24